Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Am J Surg Pathol. 2014 Apr;38(4):437–447. doi: 10.1097/PAS.0000000000000169

Table 2.

Clinicopathologic Features of Small Cell and Large Cell Subtypes

Small Cell
(n=17, 39%)
Large Cell
(n=27, 61%)

Mean Age
(range)
57.5
(21–82)
60.4
(29–79)
Male:Female 0.9 1.9
Tumor Location
Head 12 15
Body 1 2
Tail 3 8

Median Tumor Size (cm) (range) 3.5 (2.3–18) 4 (2–14.5)

Mitoses/10HPF*(range) 51 (21–92) 37 (21–83)

Ki67 Labeling Index (range) 75% (50–98%) 66% (40–95%)

T Stage
T1 0 1
T2 1 1
T3 12 20

Only Lymph Node Metastasis at Presentation 10 16

Any Metastasis at Presentation
Present 14 23
Absent 2 3

Median Survival (Months) (95% CI) 6 (5, 20) 16 (11, 18)

2-year DSS** 24.2% ± 11.7% 22.2% ± 8.7%

5-year DSS** 16.2% ± 10.2% 16.6% ± 8.1%
*

HPF High power field

**

DSS disease-specific survival (expressed as mean ± standard error)